A 970 New Jersey General Assembly · 2026-2027 Regular Session

Appropriates $2.5 million to DOBI to reimburse joint insurance funds for COVID-19 surveillance testing.

This bill appropriates $2.5 million from the state General Fund to the Department of Banking and Insurance (DOBI) to reimburse joint insurance funds for covering COVID-19 surveillance testing costs. It directly affects insurance plans providing group health coverage to "covered workers" (defined in Governor Murphy's executive orders), specifically for weekly testing of unvaccinated, asymptomatic employees in healthcare and high-risk settings from August 2021 to August 2022. The reimbursement covers costs incurred by insurance funds that voluntarily provided this testing despite federal guidance not requiring it. The bill establishes a process for funds to request reimbursement through DOBI and clarifies that "surveillance testing" refers to routine screening to identify asymptomatic cases, distinct from required medical testing.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2026 Last action Jan 13, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Jan 13, 2026
Introduced
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Carol Murphy
Carol Murphy
DDemocratic
NJ
7